Allurion

Do well by doing good. Join us in the fight against obesity. COMPANY OVERVIEW Allurion has developed and commercialized the world’s first weight loss platform—including devices, digital therapeutics, and nutritional programs—to help treat obesity. The company has already treated over 89,00 patients, shed an estimated 2 million pounds, and grown revenues at 100%+ CAGR over the past 4 years. We're headquartered outside of Boston, with offices in Paris, Dubai and Hong Kong. The company was founded in 2009 on Harvard Medical School's campus, to build alternative options to treat and empower millions of patients. We developed the Elipse™ device, and we manufacture and market the Allurion™ Program – a breakthrough in weight loss therapy. Patients lose on average 10-15% total body weight loss over the four-month course of device therapy, which does not require surgery, endoscopy or anesthesia. For more information, visit our website www.allurion.com The talent and dedication of the people working at Allurion make everything we do possible. If you're passionate about having an impact on accelerating obesity treatment and improving patient care, we'd love to hear from you.